Outcome heterogeneity of TP53-mutated myeloid neoplasms and the role of allogeneic hematopoietic cell transplantation

Haematologica. 2024 Mar 1;109(3):948-952. doi: 10.3324/haematol.2023.283886.
No abstract available

Publication types

  • Letter

MeSH terms

  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Neoplasms*
  • Tumor Suppressor Protein p53 / genetics

Substances

  • TP53 protein, human
  • Tumor Suppressor Protein p53